|
RPF1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.22044604925031E-16 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.13076215058072E-12 |
| Normal-vs-Stage2 |
2.00689999999559E-05 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.72506453566257E-12 |
| Stage1-vs-Stage2 |
8.143600E-01 |
| Stage1-vs-Stage3 |
3.014700E-04 |
| Stage1-vs-Stage4 |
2.339900E-02 |
| Stage2-vs-Stage3 |
2.648500E-02 |
| Stage2-vs-Stage4 |
1.085440E-01 |
| Stage3-vs-Stage4 |
4.241200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.62458935193399E-12 |
| Normal-vs-AfricanAmerican |
4.04669964204629E-10 |
| Normal-vs-Asian |
7.646200E-02 |
| Caucasian-vs-AfricanAmerican |
5.767400E-01 |
| Caucasian-vs-Asian |
2.640600E-01 |
| AfricanAmerican-vs-Asian |
2.307200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
<1E-12 |
| Normal-vs-Female |
8.13005218702756E-12 |
| Male-vs-Female |
2.785600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.68220000005415E-07 |
| Normal-vs-Age(41-60Yrs) |
2.00939265226907E-12 |
| Normal-vs-Age(61-80Yrs) |
1.6251444634463E-12 |
| Normal-vs-Age(81-100Yrs) |
1.70860000037187E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.640400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.322400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.738000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.911400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.344400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.350600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.881900E-03 |
| Normal-vs-Grade 2 |
2.14579998214504E-09 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.66022751102446E-12 |
| Grade 1-vs-Grade 2 |
6.347400E-01 |
| Grade 1-vs-Grade 3 |
2.495700E-02 |
| Grade 1-vs-Grade 4 |
2.688100E-02 |
| Grade 2-vs-Grade 3 |
1.60666999999837E-05 |
| Grade 2-vs-Grade 4 |
4.379600E-04 |
| Grade 3-vs-Grade 4 |
5.366800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.54770005092553E-09 |
| Normal-vs-ccB subtype |
1.62458935193399E-12 |
| ccA subtype-vs-ccB subtype |
4.8625999999885E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.66777702759191E-12 |
| Normal-vs-N1 |
5.98409999996719E-07 |
| N0-vs-N1 |
2.631600E-01 |
|
|
